Coronary artery bypass grafting in a patient initially presenting with systemic lupus erythematosus

Koichi Maeda1, Hiroyuki Nishi, Taichi Sakaguchi

  • 1Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Insights

This case study highlights managing a patient with both coronary artery disease and systemic lupus erythematosus (SLE) undergoing urgent heart surgery. Careful steroid dose adjustment alongside infection monitoring was key to successful recovery.

Area of Science:

  • Cardiology
  • Rheumatology
  • Critical Care Medicine

Background:

  • Systemic lupus erythematosus (SLE) poses unique challenges in patients requiring cardiovascular surgery.
  • Concomitant coronary artery disease (CAD) and SLE necessitates a multidisciplinary approach for optimal surgical outcomes.

Observation:

  • A 51-year-old male with CAD and SLE underwent urgent coronary artery bypass grafting (CABG).
  • Steroid therapy was initiated postoperatively due to SLE exacerbation, complicated by persistent infection and fever.
  • Steroid dose reduction led to SLE worsening, requiring careful management of infection and renal function.

Findings:

  • Gradual steroid dose regulation, balancing SLE control with infection risk, was crucial.
  • Close monitoring of infection markers and renal function guided therapeutic adjustments.
  • The patient stabilized and was discharged on postoperative day 60 without complications.

Implications:

  • Acute SLE management requires meticulous perioperative strategies in patients undergoing open-heart surgery.
  • Balancing immunosuppression and infection control is paramount in SLE patients with cardiovascular disease.
  • This case underscores the need for individualized postoperative care plans in complex autoimmune and cardiac conditions.